Arm Use With Soft-robotic Glove

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorRoessingh Research and Development

About this trial

This study, aimed at investigating the impact of using a supportive soft-robotic glove on actual arm and hand use in daily life, is designed as a single-case experimental design study. 3-5 patients with limitations in hand function due to trauma-related or neurological conditions are asked to participate. Participants will be asked to use a soft-robotic glove at home for six weeks during daily activities relevant to them, while that glove supports the grip of their most affected hand. For several weeks before, during and after the use of the soft-robotic glove, participants will be asked to do some short tests (wearing an activity meter on both wrists during the day, performing a hand squeeze test under the supervision of the researcher via video call) and to answer some questions related to perceived hand function and well-being (a total of at least 15 times during 12-14 weeks). The present study is a follow-up to previous studies that investigated the effect of (previous versions of) the same robotic glove (Carbonhand; Bioservo Technolo-gies AB, Kista, Sweden) on hand function, in order to better understand and explain the observed therapeutic effect.

Eligibility criteria

Qualifiers

Age between 18 and 90 years

Experience difficulties in performing ADL due to hand function limitations as a result of trauma-related injury or neurologic disorder

Being in a chronic/stable phase of disease as judged by their physician

Able to activate the soft-robotic glove by generating pressure on finger/palm sensors when grasping an object

Disqualifiers

Severe sensory problems of the most-affected hand

Severe acute pain of the most-affected hand

Wounds on the hands that can provide a problem when using the glove

Severe contractures limiting passive range of motion to the extent that the glove can't be donned/activated comfortably

Trial design

Treatments tested in this trial

  • Carbonhand

Treatment groups

5 Participants
are divided into 3 treatment groups

Sponsors and collaborators